News
Posaconazole prophylaxis was effective in children with ALL undergoing chemotherapy
- Author:
- Mark S. Lesney, PhD
Targeted posaconazole prophylaxis was effective in preventing invasive fungal infection in children with ALL undergoing induction chemotherapy.
News
MM patients with concurrent AL show poor survival when coupled to cardiac dysfunction
- Author:
- Mark S. Lesney, PhD
Cardiac dysfunction is a major determinant of poor survival in multiple myeloma patients with concurrent light chain amyloidosis.
News
HSCT or systemic treatment should be offered to HIV+ patients with lymphoma
- Author:
- Mark S. Lesney, PhD
Patients with lymphoma and HIV infection benefit from systemic or stem cell therapy, but with worse outcomes...
News
Heavy menstrual bleeding difficult to control in young patients with inherited platelet disorders
- Author:
- Mark S. Lesney, PhD
Consensus and a broadly effective treatment for heavy menstrual bleeding was not found among the patients with inherited platelet function...
News
Transitioning regimen may prolong proteasome inhibitor–based therapy for MM
- Author:
- Mark S. Lesney, PhD
Transitioning from parenteral bortezomib-based induction to all-oral ixazomib-lenalidomide-dexamethasone increased PI-based treatment adherence/...
News
FDA approves selinexor for relapsed/refractory DLBCL
- Author:
- Mark S. Lesney, PhD
Selinexor is approved for adults with relapsed/refractory DLBCL, including DLBCL arising from follicular...
News
Oxidatative stress–related genetic variant tied to stroke risk in sickle cell patients
- Author:
- Mark S. Lesney, PhD
SOD2 Val16Ala polymorphism may represent a simple and inexpensive alternative for identifying sickle cell patients at risk of stroke.
News
First-in-kind anti-CD47 antibody shows promise for MDS and AML treatment
- Author:
- Mark S. Lesney, PhD
Magrolimab/azactydine (AZA) improved outcomes in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS...
News

Subcutaneous hep A vaccination as effective as intramuscular for bleeding disorder patients
- Author:
- Mark S. Lesney, PhD
Subcutaneous hepatitis A vaccination is as effective and may be safer for patients with bleeding disorders....
News

Added rituximab was effective in children and adolescents with high-risk B-cell NHL
- Author:
- Mark S. Lesney, PhD
Adding rituximab to chemotherapy was effective in children and adolescents with high-risk, high-grade, mature B-...
News

Acute lymphoblastic leukemia can be successfully treated in the frail elderly
- Author:
- Mark S. Lesney, PhD
Attenuated chemotherapy shows effectiveness in frail and elderly ALL patients.
News

EHA webinar addresses treating AML patients with COVID-19
- Author:
- Mark S. Lesney, PhD
Patient isolation, treatment delays, and drug-drug interactions are key considerations when treating acute...